Short Communication
Variability of High-Sensitivity C-Reactive Protein in Chronic Heart FailureAraújo J.P.a · Friões F.a · Azevedo A.a, b · Lourenço P.a · Rocha-Gonçalves F.a · Ferreira A.a · Bettencourt P.aaHeart Failure Clinic, Serviço de Medicina Interna, Hospital S. João, e bServiço de Higiene e Epidemiologia, Faculdade de Medicina da Universidade do Porto, Unidade I&D Cardiovascular do Porto, Porto, Portugal
|
|
Cardiology 2009;113:180–183
Do you have an account?
To view the fulltext, please log in
To view the pdf, please log in
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details
Received: May 28, 2008
Accepted: October 02, 2008
Published online: January 09, 2009
Issue release date: May 2009
Number of Print Pages: 4
Number of Figures: 1
Number of Tables: 2
ISSN: 0008-6312 (Print)
eISSN: 1421-9751 (Online)
For additional information: https://www.karger.com/CRD
First-Page Preview
Related Articles:
References
- Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL: Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201–1206.
- Backes JM, Howard PA, Moriarty PM: Role of C-reactive protein in cardiovascular disease. Ann Pharmacother 2004;38:110–118.
- Steele IC, Nugent AM, Maguire S, Hoper M, Campbell G, et al: Cytokine profile in chronic cardiac failure. Eur J Clin Invest 1996;26:1018–1022.
- Chirinos JA, Zambrano JP, Chakko S, Schob A, Veerani A, et al: Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy. Am J Cardiol 2005;95:88–90.
- Windram JD, Loh PH, Rigby AS, Hanning I, Clark AL, Cleland JG: Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. Am Heart J 2007;153:1048–1055.
- Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, et al: Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J 2004;147:931–938.
- Lamblin N, Mouquet F, Hennache B, Dagorn J, Susen S, et al: High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J 2005;26:2245–2250.
- Macy EM, Hayes TE, Tracy RP: Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological. Clin Chem 1997;43:52–58.
- Bogaty P, Brophy JM, Boyer L, Simard S, Joseph L, et al: Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch Intern Med 2005;165:221–226.
- Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, et al: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115–1140.
- Chenilot O, Henny J, Steinmetz J, Herbeth B, Wagner C, Siest G: High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem Lab Med 2000;38:1003–1011.
-
McGraw KO, Wong SP: Forming some inferences about some intraclass correlation coefficients. Psychological Methods 1996;1:30–46.
External Resources
- Mann DL: Inflammatory mediators and the failing heart: past, present and the foreseeable future. Circ Res 2002;91:988–998.
- Ishikawa C, Tsutamoto T, Fujii M, Sakai H, Tanaka T, Horie M: Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy. Circ J 2006;70:857–863.
Article / Publication Details
Received: May 28, 2008
Accepted: October 02, 2008
Published online: January 09, 2009
Issue release date: May 2009
Number of Print Pages: 4
Number of Figures: 1
Number of Tables: 2
ISSN: 0008-6312 (Print)
eISSN: 1421-9751 (Online)
For additional information: https://www.karger.com/CRD
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID